Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Systemic Inflammation in Patients With Atherosclerotic Cardiovascular Disease and Heart Failure

NCT06122961 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT06122961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06122961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Systemic Inflammation in Patients With Atherosclerotic Cardiovascular Disease and Heart Failure
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
November 23, 2023
Completion date
April 30, 2025
Enrollment
18,198 (actual)
Sites
195

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular risk, chronic kidney disease, heart failure